Jennifer L. Harris

Jennifer Harris leads Sequoia’s clinical development programs. In this role, Jennifer will be responsible for leading the clinical and regulatory strategies for the Sequoia pipeline including interactions with the FDA and other country regulatory authorities as well as responsibility for the design, implementation, and execution of clinical trials. Jennifer has over 20 years of pharmaceutical industry experience involving 20 IND programs and 3 NDA/BLA submissions. Her experience encompasses big pharma, biotech as well as emerging biotech inclusive of roles in clinical development, regulatory affairs, and medical affairs. Jennifer has particular expertise in immune therapies for the treatment of cancer and infectious diseases. She has held clinical positions at major academic centers as well as the National Institutes of Health (NIH) and industry experience at GlaxoSmithKline, Merck & Co., Celgene, Dendreon, Heat Biologics, and most recently she lead a team of clinical scientists at Syneos Health focused on clinical development activities. Jennifer holds a Bachelor of Science and Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill.